SCHEDULE 13G/A: Sio Capital Management Discloses 3.63% Stake in Ventyx Biosciences

Sio Capital Management, LLC has filed an amended Schedule 13G, reporting a 3.63% beneficial ownership stake in Ventyx Biosciences, Inc. as of March 31, 2025.

Summary

• Sio Capital Management, LLC, a Delaware limited liability company and registered investment adviser, reported beneficial ownership of 2,582,655 shares of Ventyx Biosciences, Inc. Common Stock.
• This ownership represents 3.63% of Ventyx Biosciences, Inc.'s outstanding common stock.
• The calculation is based on 71,130,054 shares of common stock outstanding as of February 24, 2025, as reported in the Issuer's Form 10-K filed on February 27, 2025.
• Sio Capital Management, LLC holds shared voting power and shared dispositive power over all 2,582,655 shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported stake.
• Sio Capital Management, LLC acts as an investment adviser to certain affiliated funds that directly hold these shares for the benefit of their respective investors.

Sentiment

Score: 5

Explanation: The document is a factual, routine regulatory filing (Schedule 13G Amendment No. 1) disclosing beneficial ownership. It contains no inherently positive or negative news about the issuer's operations or financial performance, thus maintaining a neutral sentiment.

Positives

• The filing indicates continued institutional interest in Ventyx Biosciences, Inc. by Sio Capital Management, LLC.

Negatives

• The document does not contain any negative information regarding Ventyx Biosciences, Inc. or Sio Capital Management, LLC.

Risks

• The document notes that Sio GP, LLC and Michael Castor (who controls both Sio and Sio GP, LLC) may be deemed beneficial owners of the Common Stock, but they expressly disclaim such beneficial ownership for purposes of Section 13(d) of the Exchange Act.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding Ventyx Biosciences, Inc.'s future performance or Sio Capital Management, LLC's future investment intentions beyond the current ownership disclosure.

Industry Context

This filing is a routine disclosure by an investment adviser, Sio Capital Management, LLC, regarding its passive investment stake in Ventyx Biosciences, Inc., a publicly traded company. It reflects an institutional investor's position in the market, which is a common occurrence in the financial industry.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming Sio Capital Management, LLC's passive investment intent.
• Investment Professionals: Offers data for tracking institutional ownership and potential investment trends in Ventyx Biosciences, Inc.

Key Dates

Keywords

Ventyx Biosciences, Sio Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Institutional Investor, Equity Stake